Results 71 to 80 of about 2,190 (195)

Iatrogenic Blepharoptosis: Multimodal Management and Treatment Technique With Botulinum Toxin Type A

Dermatology Research and Practice, Volume 2025, Issue 1, 2025.
Blepharoptosis as an Aesthetic Complication Eyelid ptosis, or blepharoptosis, following esthetic treatment of the upper third with botulinum toxin Type A (BoNT‐A) is a complication with a variable incidence depending on the injector’s experience. Among unexperienced injectors, it ranges from 2.5% to 5.4% and approximately 0.51% to 1% in experienced ...
Rengifo-Palacios Jaime Alberto, Macías-Arias Paola Andrea, Uribe-Posada Maria Paulina, Lopera-Botero Luisa, Tulika Banerjee   +4 more
wiley   +1 more source

Terápiás ajánlás rosacea leggyakoribb klinikai altípusaiban = Subtype directed treatment recommendation for rosacea [PDF]

, 2015
A rosacea az arc jellemzően középső területének bőrét érintő, krónikus, gyulladásos betegség. Korábban az acne vulgaris altípusának tartották és "acne rosacea" terminológiával illették. Önálló entitásként először Hebra írta le az 1850-es években.
Baltás, Eszter, Csörgő Sándorné Bata, Zsuzsanna, Holló, Péter, Lengyel, Zsuzsanna, Szegedi, Andrea   +4 more
core  

A Systematic Review of Ocular Complications Following Different Types of Covid‐19 Vaccines

Journal of Immunology Research, Volume 2025, Issue 1, 2025.
Introduction More than 6 million deaths from the novel coronavirus, the Coronavirus disease 2019 (COVID‐19) infection, have prompted the development of several prophylactic vaccines of COVID‐19. This systematic review summarizes the ocular complications of various COVID‐19 vaccinations, diseases diagnosed, treatment, and risk factors.
Bahareh Ebrahimi, Hossein Kargar Jahromi, Nazanin Shafiei Jahromi, Mina Molayem, Poorani Gurumallesh   +4 more
wiley   +1 more source

Tools for clinical pharmacists to identify medications that can cause drug‐induced cognitive impairment: A systematic review

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 7, Issue 12, Page 1207-1227, December 2024.
Abstract Cognitive impairment affects around 19% of community‐dwelling older adults in the United States. Pharmacists can play a significant role in identifying and deprescribing cognitive‐impairing medications through cognitive‐focused medication reviews or as part of comprehensive medication management.
Jacob Stanton, Michael R. Gionfriddo, Gail B. Rattinger, Yuan Fang, Mia E. Lussier   +4 more
wiley   +1 more source

Novel Uses of Brimonidine

Delhi Journal of Ophthalmology
Brimonidine tartrate is a third-generation, highly selective alpha 2 agonist currently available in various formulations and doses to treat ophthalmological conditions. The aim of this article was to review pharmacokinetics, mechanisms, side effects, and
Hikkalagutti. S. Kruthika, Chauhan Tulika, Patyal Sagarika, Bhardwaj Kanika, Dabas Garvita   +4 more
doaj   +1 more source

Nummular keratitis: A rare manifestation of brimonidine allergy

Oman Journal of Ophthalmology
A 32-year-old male, with juvenile open-angle glaucoma on chronic antiglaucoma therapy and recently introduced brimonidine eye drops to the treatment regimen, developed bilateral follicular conjunctivitis with subepithelial infiltrates (SEIs) initially ...
Maitha Al Asmi, Aisha Al Busaidi
doaj   +1 more source

Fabrication and efficacy assessment of combination of brimonidine and ivermectin for treatment of papulopustular rosacea

Journal of Cosmetic Dermatology, Volume 23, Issue 9, Page 2973-2981, September 2024.
Abstract Background & Aim Rosacea is a chronic inflammatory, multifactorial disease for which combination therapy could be an effective treatment. In this study, we evaluate the effect of the combination therapy of brimonidine 0.33% and ivermectin 1% as a single cream for the treatment of papulopustular rosacea.
Samin Fallah Pakdaman, Aniseh Samadi, Mahsa Fattahi, Atefeh Naeimifar, Fatemeh Amiri Ardehali, Yasaman Ketabi, Saman Ahmad Nasrollahi, Alireza Firooz   +7 more
wiley   +1 more source

Brimonidine tartrate effect on retinal spreading depression depends on Müller cells

Revista Brasileira de Oftalmologia, 2014
Objective: Demonstrate the Brimonidine effect over Retinal Spreading Depression (SD). Brimonidine is an alpha-2–adrenergic receptor agonist, used in the management of glaucoma. Alpha2-agonists have been shown to be neuroprotective in various experimental
Vinícius Vanzan Pimentel de Oliveira, Marcio Penha Morterá Rodrigues, Adroaldo de Alencar, Sebastião Cronemberger, Nassim Calixto, Adalmir Morterá Dantas   +5 more
doaj   +1 more source

Visionary Spring 2011 [PDF]

, 2011
https://nsuworks.nova.edu/hpd_opt_visionary/1006/thumbnail ...
College of Optometry
core   +2 more sources

The relationship between corneal calcareous degeneration and various ophthalmic diseases in dogs: A retrospective study

Veterinary Ophthalmology, Volume 27, Issue 5, Page 406-413, September 2024.
Abstract Objective To investigate ocular factors that influence the development of corneal calcareous degeneration (CCD) in dogs. Animals and Procedures The medical records of 96 eyes of dogs with CCD and 288 eyes without CCD were retrospectively reviewed. Dogs with evidence of causative systemic illness associated with CCD were excluded from the study.
Dajeong Jeong, Seonmi Kang, Eunji Lee, Kangmoon Seo   +3 more
wiley   +1 more source